Federal Register / Vol. 62, No. 53 / Wednesday, March 19, 1997 / Notices 13161

Time: 7:30 p.m.

Place: University of Florida, Gainesville,

Florida 32610.

Contact Person: Lakshmanan Sankaran,

Ph.D., Scientific Review Administrator,

Natcher Building, Room 6as–25F, National

Institutes of Health, Bethesda, Maryland

20892–6600, Phone: 301–594–7799.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

sections 552b(c)(4) and 552b(c)(6), Title 5

U.S.C. Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Disease; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health.)

Dated: March 14, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–6945 Filed 3–18–97; 8:45 am]

BILLING CODE 4140–01–M

National Library of Medicine; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C., Appendix 2), notice

is hereby given of the following

National Library of Medicine Special

Emphasis Panel (SEP) meeting:

Name of SEP: National Library of Medicine

Special Emphasis Panel.

Date: March 31–April 2, 1997.

Time: 7:00 p.m.

Place: University of Rochester, Rochester,

NY 14642.

Contact: Dr. Roger W. Dahlen, Chief,

Biomedical Information Support Branch, EP,

8600 Rockville Pike, Bldg. 38A, Rm. 5S–522,

Bethesda, Maryland 20894, 301/496–4221.

Purpose/Agenda: To evaluate and review

IAIMS grant applications.

The meeting will be closed in

accordance with the provisions set forth

in sections 552b(c)(4) and 552b(c)(6),

Title 5, U.S.C. Applications and/or

proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

This notice is being published less

than 15 days prior to the meeting due

to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

(Catalog of Federal Domestic Assistance

Program No. 93–879—Medical Library

Assistance, National Institutes of Health.)

Dated: March 12, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–6859 Filed 3–18–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Meeting President’s Cancer Panel

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

President’s Cancer Panel.

This meeting will be open to the

public as indicated below, with

attendance by the public limited to

space available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below.

Linda Quick-Cameron, Committee

Management Officer, National Cancer

Institute, Executive Plaza North, Room

630E, 6130 Executive Blvd., MSC 7410,

Bethesda, MD 20892–7410 (301/496–

5708) will provide a summary of the

meeting and the roster of committee

members upon request. Other

information pertaining to the meeting

may be obtained from the contract

person indicated below.

Committee Name: President’s Cancer

Panel.

Date: April 9, 1997.

Place: Herbert Irving Comprehensive

Cancer Center, Columbia University, 630

West 168th Street, PH 18–200, New York,

New York 10032.

Open: 8:30 a.m. to 5:30 p.m.

Agenda: Concerns of Special Populations

in the National Cancer Program: The

Meaning of Race in Science—Considerations

for Cancer Research.

Contact Person: Maureen O. Wilson, Ph.D,

Executive Secretary, National Cancer

Institute, Building 31, Room 4A48, Bethesda,

MD 20892–2473, Telephone: (301) 496–1148.

Dated: March 12, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–6857 Filed 3–18–97; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Biological and Physiological

Sciences.

Date: March 21, 1997.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 6172,

Telephone Conference.

Contact Person: Dr. Cheryl Corsaro,

Scientific Review Administrator, 6701

Rockledge Drive, Room 6172, Bethesda,

Maryland 20892, (301) 435–1045.

Name of SEP: Clinical Sciences.

Date: March 26, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4118,

Telephone Conference.

Contact Person: Dr. Christine Melchior,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4118, Bethesda,

Maryland 20892, (301) 435–1713.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Clinical Sciences.

Date: April 3, 1997.

Time: 11:30 a.m.

Place: NIH, Rockledge 2, Room 4214,

Telephone Conference.

Contact Person: Dr. Dan McDonald,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4214, Bethesda,

Maryland 20892, (301) 435–1215.

Name of SEP: Clinical Sciences.

Date: April 3, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4214,

Telephone Conference..

Contact Person: Dr. Dan McDonald,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4214, Bethesda,

Maryland 20892, (301) 435–1215.

Name of SEP: Clinical Sciences.

Date: April 3, 1997.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 4214,

Telephone Conference.

Contact Person: Dr. Dan McDonald,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4214, Bethesda,

Maryland 20892, (301) 435–1215.

Name of SEP: Biological and Physiological

Sciences.

Date: April 4–5, 1997.

Time: 9:00 a.m.

Place: River Inn, Washington, DC.

Contact Person: Dr. Cheryl Corsaro,

Scientific Review Administrator, 6701

Rockledge Drive, Room 6172, Bethesda,

Maryland 20892, (301) 435–1045.

Name of SEP: Clinical Sciences.

Date: April 7, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4214,

Telephone Conference.

Contact Person: Dr. Dan McDonald,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4214, Bethesda,

Maryland 20892, (301) 435–1215.

Name of SEP: Clinical Sciences.